Expression of endothelial and inducible nitric oxide synthases and nitric oxide production in ovine placental and uterine tissues during late pregnancy

Placenta

Volumn 21, Issue 5-6, 2000, Pages 516-524

  Zheng, J ^a   Li, Y ^a   Weiss, A R ^a   Bird, I M ^a   Magness, R R ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ISOENZYME; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE;

ANIMAL TISSUE; ARTICLE; CHEMOLUMINESCENCE; CHORIOALLANTOIS; ENDOMETRIUM; ENZYME INDUCTION; ENZYME LOCALIZATION; FEMALE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PLACENTA; PLACENTA CIRCULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHEEP; STROMA CELL; THIRD TRIMESTER PREGNANCY; TISSUE DISTRIBUTION; WESTERN BLOTTING;

EID: 0033854076     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1053/plac.1999.0504     Document Type: Article

References (38)

1. Hormonal regulation of angiotensin II type I receptor expression and ATI-R mRNA levels in human adrenocortical cells
2. Effect of endothelium-derived relaxing factor inhibition on the umbilical-placental circulation in fetal lambs in utero
3. Estrogen modulates paracellular permeability of human endothelial cells by eNOS-and iNOS-related mechanisms
4. Nitric oxide-mediated changes in vascular reactivity in pregnancy in spontaneously hypertensive rats
5. Expression of nitric oxide synthase by syncytiotrophoblast in human placental villi
6. Identification of increased nitric oxide biosynthesis during pregnancy in rats
7. Nitric oxide mediates cytotoxicity and basic fibroblast growth factor release in cultured vascular smooth muscle cells. A possible mechanism of neovascularization in atherosclerotic plaques
8. Angiotensin II vascular smooth-muscle receptors are not down-regulated in near-term pregnant sheep
9. Renin-angiotensin system and uterine vascular function
10. Angiotensin II metabolic clearance rate and pressor responses in nonpregnant and pregnant women
11. Circulatory changes during gestation
12. 2 and NO in pregnancy
13. Prolonged unilateral uterine infusion of L-NAME increases uterine and systemic vascular responsiveness to infused angiotensin II in pregnancy
14. Endothelial vasodilator production by uterine and systemic arteries: II. Pregnancy effects on NO synthase expression
15. Functional characteristics of small placental arteries
16. The action of nitric oxide in the perfused human fetal-placental circulation
17. Immunohistochemical localization of nitric oxide synthase in the human placenta
18. Nω-nitro-L-arginine, an inhibitor of nitric oxide synthesis, increases blood pressure in rats and reverses the pregnancy-induced refractoriness to vasopressor agents
19. Localization of nitric oxide synthases and nitric oxide production in the rat mammary gland
20. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase 1/2 activation in postcapillary endothelium
21. Nitric Oxide (NO) modulates angiogenic factor induced proliferation via MAPK in ovine fetal placental arterial endothelial (OFPAE) cells
22. Nitric oxide synthase activities in human myometrium and villous trophoblast throughout pregnancy
23. Ontogeny of angiotensin II vascular smooth muscle receptors in ovine fetal aorta and placental and uterine arteries
24. Comparison of angiotensin II in fetal and pregnant sheep. Metabolic clearance and vascular sensitivity
25. Nitric oxide and pregnancy
26. Biochemistry of nitric oxide and its redox-activated forms
27. Gestational changes in nitric oxide synthase activity in the rat placenta
28. Estrogen and lipopolysaccharide stimulation of prostacyclin production and the levels of cyclooxygenase and nitric oxide synthase in ovine uterine arteries
29. Endothelial vasodilator production by uterine and systemic arteries. III. Ovarian and estrogen effects on NO synthase
30. Ovine adrenal fasciculata cells contain angiotensin-II receptors coupled to intracellular effectors but are resistant to the steroidogenic effects of this hormone
31. Angiotensin II and a-agonist: I. Responses of ovine fetoplacental vasculature
32. Comparative localization of endothelial and inducible nitric oxide synthase isoforms in haemochorial and epitheliochorial placentae
33. Adventitia as a source of inducible nitric oxide synthase in the rat aorta
34. Expression of basic fibroblast growth factor, endothelial mitogenic activity, and angiotensin II type-I receptors in the ovine placenta during the third trimester of pregnancy
35. A cell model for studying expression of feto-placental artery endothelial cell angiotensin II type-I receptors and nitric oxide synthase
36. Characterization of heparin-binding endothelial mitogen(s) produced by the ovine endometrium during early pregnancy
37. Activation of the mitogen-activated protein kinase cascade is necessary but not sufficient for basic fibroblast growth factor and epidermal growth factor stimulated expression of endothelial nitric oxide synthase
38. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis